Medifast Inc (MED)

$26.69

+0.76

(+2.93%)▲

Market is closed - opens 7 PM, 06 May 2024

Insights on Medifast Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 348.98M → 191.01M (in $), with an average decrease of 18.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 39.96M → 6.03M (in $), with an average decrease of 40.6% per quarter

  • Vs HRB

    In the last 1 year, H&r Block, Inc. has given 46.6% return, outperforming this stock by 117.3%

  • Vs HRB

    In the last 3 years, H&r Block, Inc. has given 108.0% return, outperforming this stock by 197.4%

Performance

  • $25.36
    $26.78
    $26.69
    downward going graph

    4.98%

    Downside

    Day's Volatility :5.3%

    Upside

    0.34%

    downward going graph
  • $25.92
    $107.29
    $26.69
    downward going graph

    2.88%

    Downside

    52 Weeks Volatility :75.84%

    Upside

    75.12%

    downward going graph

Returns

PeriodMedifast IncSector (Consumer Staples)Index (Russel 2000)
3 Months
-48.35%
2.9%
0.0%
6 Months
-62.23%
10.4%
0.0%
1 Year
-70.66%
-1.7%
0.5%
3 Years
-89.42%
8.8%
-21.1%

Highlights

Market Capitalization
367.3M
Book Value
$18.69
Dividend Share
4.95
Dividend Yield
19.7%
Earnings Per Share (EPS)
9.1
PE Ratio
3.7
PEG Ratio
1.95
Wall Street Target Price
37.5
Profit Margin
9.27%
Operating Margin TTM
4.54%
Return On Assets TTM
25.24%
Return On Equity TTM
55.77%
Revenue TTM
1.1B
Revenue Per Share TTM
98.5
Quarterly Revenue Growth YOY
-43.4%
Gross Profit TTM
1.1B
EBITDA
139.5M
Diluted Eps TTM
9.1
Quarterly Earnings Growth YOY
-0.77
EPS Estimate Current Year
1.9
EPS Estimate Next Year
3.13
EPS Estimate Current Quarter
0.96
EPS Estimate Next Quarter
1.49

Analyst Recommendation

Sell
    0
    0%Buy
    44%Hold
    55%Sell
Based on 9 Wall street analysts offering stock ratings for Medifast Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
4
3
3
Sell
5
5
5

Analyst Forecast

What analysts predicted

Upside of 40.5%

Current $26.69
Target $37.50

Company Financials

FY18Y/Y Change
Revenue
501.0M
↑ 66.14%
Net Income
55.8M
↑ 101.25%
Net Profit Margin
11.14%
↑ 1.95%
FY19Y/Y Change
Revenue
713.7M
↑ 42.45%
Net Income
77.9M
↑ 39.66%
Net Profit Margin
10.92%
↓ 0.22%
FY20Y/Y Change
Revenue
934.8M
↑ 30.99%
Net Income
102.9M
↑ 32.01%
Net Profit Margin
11.0%
↑ 0.08%
FY21Y/Y Change
Revenue
1.5B
↑ 63.25%
Net Income
164.0M
↑ 59.47%
Net Profit Margin
10.75%
↓ 0.25%
FY22Y/Y Change
Revenue
1.6B
↑ 4.75%
Net Income
143.6M
↓ 12.48%
Net Profit Margin
8.98%
↓ 1.77%
FY23Y/Y Change
Revenue
1.1B
↓ 32.94%
Net Income
99.4M
↓ 30.75%
Net Profit Margin
9.27%
↑ 0.29%
Q3 FY22Q/Q Change
Revenue
390.4M
↓ 13.88%
Net Income
36.2M
↓ 7.56%
Net Profit Margin
9.26%
↑ 0.63%
Q4 FY22Q/Q Change
Revenue
337.2M
↓ 13.62%
Net Income
26.5M
↓ 26.65%
Net Profit Margin
7.86%
↓ 1.4%
Q1 FY23Q/Q Change
Revenue
349.0M
↑ 3.48%
Net Income
40.0M
↑ 50.72%
Net Profit Margin
11.45%
↑ 3.59%
Q2 FY23Q/Q Change
Revenue
296.2M
↓ 15.13%
Net Income
30.3M
↓ 24.24%
Net Profit Margin
10.22%
↓ 1.23%
Q3 FY23Q/Q Change
Revenue
235.9M
↓ 20.37%
Net Income
23.1M
↓ 23.61%
Net Profit Margin
9.81%
↓ 0.41%
Q4 FY23Q/Q Change
Revenue
191.0M
↓ 19.02%
Net Income
6.0M
↓ 73.91%
Net Profit Margin
3.16%
↓ 6.65%
FY18Y/Y Change
Total Assets
169.4M
↑ 16.1%
Total Liabilities
60.3M
↑ 61.52%
FY19Y/Y Change
Total Assets
194.7M
↑ 14.89%
Total Liabilities
89.8M
↑ 48.9%
FY20Y/Y Change
Total Assets
276.1M
↑ 41.83%
Total Liabilities
118.8M
↑ 32.31%
FY21Y/Y Change
Total Assets
398.3M
↑ 44.28%
Total Liabilities
195.9M
↑ 64.81%
FY22Y/Y Change
Total Assets
316.2M
↓ 20.61%
Total Liabilities
161.2M
↓ 17.71%
FY23Y/Y Change
Total Assets
309.9M
↓ 1.99%
Total Liabilities
108.4M
↓ 32.72%
Q3 FY22Q/Q Change
Total Assets
326.4M
↓ 4.17%
Total Liabilities
175.8M
↓ 16.7%
Q4 FY22Q/Q Change
Total Assets
316.2M
↓ 3.11%
Total Liabilities
161.2M
↓ 8.34%
Q1 FY23Q/Q Change
Total Assets
321.6M
↑ 1.71%
Total Liabilities
150.7M
↓ 6.49%
Q2 FY23Q/Q Change
Total Assets
318.7M
↓ 0.9%
Total Liabilities
133.2M
↓ 11.64%
Q3 FY23Q/Q Change
Total Assets
320.0M
↑ 0.41%
Total Liabilities
127.0M
↓ 4.64%
Q4 FY23Q/Q Change
Total Assets
309.9M
↓ 3.16%
Total Liabilities
108.4M
↓ 14.61%
FY18Y/Y Change
Operating Cash Flow
60.8M
↑ 40.66%
Investing Cash Flow
-1.2M
↓ 62.09%
Financing Cash Flow
-53.3M
↑ 207.15%
FY19Y/Y Change
Operating Cash Flow
84.3M
↑ 38.55%
Investing Cash Flow
-6.3M
↑ 427.77%
Financing Cash Flow
-82.3M
↑ 54.37%
FY20Y/Y Change
Operating Cash Flow
145.2M
↑ 72.32%
Investing Cash Flow
-1.3M
↓ 79.74%
Financing Cash Flow
-57.1M
↓ 30.59%
FY21Y/Y Change
Operating Cash Flow
94.5M
↓ 34.88%
Investing Cash Flow
-29.1M
↑ 2167.08%
Financing Cash Flow
-125.1M
↑ 118.98%
FY22Y/Y Change
Operating Cash Flow
194.6M
↑ 105.8%
Investing Cash Flow
-11.4M
↓ 60.73%
Financing Cash Flow
-199.6M
↑ 59.5%
Q3 FY22Q/Q Change
Operating Cash Flow
55.4M
↑ 26.58%
Investing Cash Flow
-1.8M
↓ 249.58%
Financing Cash Flow
-45.1M
↓ 55.79%
Q4 FY22Q/Q Change
Operating Cash Flow
51.7M
↓ 6.6%
Investing Cash Flow
-9.1M
↑ 412.67%
Financing Cash Flow
-24.3M
↓ 46.06%
Q1 FY23Q/Q Change
Operating Cash Flow
64.1M
↑ 23.81%
Investing Cash Flow
-2.1M
↓ 76.67%
Financing Cash Flow
-25.9M
↑ 6.43%
Q2 FY23Q/Q Change
Operating Cash Flow
43.1M
↓ 32.65%
Investing Cash Flow
-1.7M
↓ 17.54%
Financing Cash Flow
-17.8M
↓ 31.13%
Q3 FY23Q/Q Change
Operating Cash Flow
29.9M
↓ 30.63%
Investing Cash Flow
-50.3M
↑ 2785.09%
Financing Cash Flow
-18.2M
↑ 1.78%

Technicals Summary

Sell

Neutral

Buy

Medifast Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Medifast Inc
Medifast Inc
-18.7%
-62.23%
-70.66%
-89.42%
-82.43%
Service Corporation International
Service Corporation International
-6.76%
14.38%
3.86%
21.13%
58.22%
Bright Horizons Family Solutions Inc
Bright Horizons Family Solutions Inc
-0.18%
30.94%
22.54%
-19.59%
-19.59%
H&r Block, Inc.
H&r Block, Inc.
1.26%
13.82%
46.56%
108.01%
76.23%
Rollins Inc.
Rollins Inc.
1.65%
21.37%
10.41%
24.31%
84.14%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Medifast Inc
Medifast Inc
3.7
3.7
1.95
1.9
0.56
0.25
0.2
18.69
Service Corporation International
Service Corporation International
20.26
20.26
1.59
3.65
0.33
0.04
0.02
10.53
Bright Horizons Family Solutions Inc
Bright Horizons Family Solutions Inc
83.3
83.3
1.76
3.08
0.06
0.03
NA
20.97
H&r Block, Inc.
H&r Block, Inc.
12.92
12.92
0.79
4.24
0.46
0.18
0.03
-5.54
Rollins Inc.
Rollins Inc.
50.45
50.45
3.54
1.0
0.36
0.16
0.01
2.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Medifast Inc
Medifast Inc
Sell
$367.3M
-82.43%
3.7
9.27%
Service Corporation International
Service Corporation International
Buy
$10.5B
58.22%
20.26
13.11%
Bright Horizons Family Solutions Inc
Bright Horizons Family Solutions Inc
Buy
$6.2B
-19.59%
83.3
3.07%
H&r Block, Inc.
H&r Block, Inc.
Buy
$6.5B
76.23%
12.92
16.98%
Rollins Inc.
Rollins Inc.
Buy
$21.8B
84.14%
50.45
13.94%

Institutional Holdings

  • BlackRock Inc

    16.57%

  • Vanguard Group Inc

    15.48%

  • Renaissance Technologies Corp

    6.95%

  • Pacer Advisors, INC.

    4.80%

  • State Street Corporation

    3.92%

  • First Trust Advisors L.P.

    3.65%

Corporate Announcements

  • Medifast Inc Dividends March,2023

    In the quarter ending March,2023. Medifast Inc has declared dividend of $1.65

    Read More

Company Information

since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better

Organization
Medifast Inc
Employees
634
CEO
Mr. Daniel R. Chard
Industry
Retail Trade

Discover More

FAQs